172 related articles for article (PubMed ID: 33851343)
1. Potential of 1-(1-napthylmethyl)-piperazine, an efflux pump inhibitor against cadmium-induced multidrug resistance in Salmonella enterica serovar Typhi as an adjunct to antibiotics.
Kaur UJ; Chopra A; Preet S; Raj K; Kondepudi KK; Gupta V; Rishi P
Braz J Microbiol; 2021 Sep; 52(3):1303-1313. PubMed ID: 33851343
[TBL] [Abstract][Full Text] [Related]
2. Potential of 2, 2'-dipyridyl diselane as an adjunct to antibiotics to manage cadmium-induced antibiotic resistance in Salmonella enterica serovar Typhi Ty2 strain.
Rishi P; Thakur R; Kaur UJ; Singh H; Bhasin KK
J Microbiol; 2017 Sep; 55(9):737-744. PubMed ID: 28779338
[TBL] [Abstract][Full Text] [Related]
3. Increasing antimicrobial susceptibility of MDR Salmonella with the efflux pump inhibitor 1-(1-Naphthylmethyl)-piperazine.
Price EDJ; Dassanayake RP; Bearson SMD
Biochem Biophys Res Commun; 2023 Aug; 668():49-54. PubMed ID: 37244034
[TBL] [Abstract][Full Text] [Related]
4. Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds.
Schuster S; Vavra M; Wirth DAN; Kern WV
Microbiol Spectr; 2024 Feb; 12(2):e0304523. PubMed ID: 38170977
[TBL] [Abstract][Full Text] [Related]
5. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
6. Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies.
Mehta J; Rolta R; Dev K
J Ethnopharmacol; 2022 Jan; 282():114589. PubMed ID: 34492321
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
8. Sodium Malonate Inhibits the AcrAB-TolC Multidrug Efflux Pump of
Cauilan A; Ruiz C
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558743
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC.
Ricci V; Tzakas P; Buckley A; Piddock LJ
Antimicrob Agents Chemother; 2006 Jan; 50(1):38-42. PubMed ID: 16377664
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efflux pump inhibitors of MexAB- or MexXY-OprM in Pseudomonas aeruginosa using nucleic acid dyes.
Fujiwara M; Yamasaki S; Morita Y; Nishino K
J Infect Chemother; 2022 May; 28(5):595-601. PubMed ID: 35168878
[TBL] [Abstract][Full Text] [Related]
12. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
13. Characterization of putative multidrug resistance transporters of the major facilitator-superfamily expressed in Salmonella Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; De Zorzi R; Mirza O; Walz T; Rahman M
J Infect Chemother; 2015 May; 21(5):357-62. PubMed ID: 25724589
[TBL] [Abstract][Full Text] [Related]
14. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Bailey AM; Paulsen IT; Piddock LJ
Antimicrob Agents Chemother; 2008 Oct; 52(10):3604-11. PubMed ID: 18694955
[TBL] [Abstract][Full Text] [Related]
15. Lack of AcrB Efflux Function Confers Loss of Virulence on
Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
[TBL] [Abstract][Full Text] [Related]
16. A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load.
Reens AL; Crooks AL; Su CC; Nagy TA; Reens DL; Podoll JD; Edwards ME; Yu EW; Detweiler CS
PLoS Pathog; 2018 Jun; 14(6):e1007115. PubMed ID: 29879224
[TBL] [Abstract][Full Text] [Related]
17. Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in
Chen Y; Hu D; Zhang Q; Liao XP; Liu YH; Sun J
Front Cell Infect Microbiol; 2017; 7():37. PubMed ID: 28261566
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria.
Piddock LJ; Garvey MI; Rahman MM; Gibbons S
J Antimicrob Chemother; 2010 Jun; 65(6):1215-23. PubMed ID: 20304975
[TBL] [Abstract][Full Text] [Related]
20. Restraining the multidrug efflux transporter STY4874 of Salmonella Typhi by reserpine and plant extracts.
Tariq A; Sana M; Shaheen A; Ismat F; Mahboob S; Rauf W; Mirza O; Iqbal M; Rahman M
Lett Appl Microbiol; 2019 Sep; 69(3):161-167. PubMed ID: 31267555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
